Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
E. M. Struijf, K. I. De la O Becerra, M. Ruyken…·S. H. M. Rooijakkers
This study identifies and characterizes two high-affinity anti-C5 nanobodies that inhibit C5 cleavage and recognize distinct epitopes, including a variant not targeted by Eculizumab.
T. W. M. De Groof, E. G. Elder, R. Heukers…·M. J. Smit
This study develops a nanobody that partially inhibits HCMV receptor signaling and enhances T-cell killing of latently infected monocytes, offering a potential therapy for clearing HCMV reservoirs in transplant patients.
A. Amcheslavsky, A. Wallace, M. Ejemel…·Y. Wang
This study shows that oral administration of a single nanobody provides broad protection against multiple ETEC strains by targeting conserved epitopes.
M. Soave, R. Heukers, B. Kellam…·S. Hill
The paper uses nanobodies conjugated with NanoBiT to monitor ligand-induced conformational changes in the CXCR4 receptor.